ÂÜÀòÂÒÂ×

Aegle Therapeutics is a first-in-class, phase 1/2a biotechnology company isolating extracellular vesicles including exosomes ("EVs") secreted by allogeneic bone marrow derived mesenchymal stem cells to treat dystrophic epidermolysis bullosa ("DEB"), a rare genetic pediatric connective tissue disorde... Read more